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Background: Exposure to high altitude in hypobaric hypoxia (HH) is considered to be a physiological oxidative/
nitrosative stress. Quercetin (Que) is an effective antioxidant and free radical scavenger against oxidative/nitrosative
stress. Aims: The aim of this study was to investigate the cardioprotective effects of Que in animals exposed to
intermittent HH (IHH) and therefore exposed to oxidative/nitrosative stress. Materials and methods: Wistar albino
male rats were exposed to short-term (2 days) or long-term (4 weeks; 5 days/week) IHH in a hypobaric chamber
(5,500 m, 8 h/day, 380 mmHg, 12% O2, and 88% N2). Half of the animals received natural antioxidant Que (body
weight: 30 mg/kg) daily before each IHH exposure and the remaining rats received vehicle (carboxymethylcellulose
solution). Control rats were kept under normobaric normoxia (Nx) and treated in a corresponding manner. One day
after the last exposure to IHH, we measured the cardiac hypoxia-induced oxidative/nitrosative stress biomarkers: the
malondialdehyde (MDA) level and protein carbonyl (PC) content, the activity of some antioxidant enzymes
[superoxide dismutase (SOD) and catalase (CAT)], the nitrite plus nitrate (NOx) production, and the inducible
nitric oxide synthase (iNOS) protein expression. Results: Heart tissue MDA and PC levels, NOx level, and iNOS
expression of IHH-exposed rats had increased, and SOD and CAT activities had decreased compared with those of
the Nx-exposed rats (control groups). MDA, CP, NOx, and iNOS levels had decreased in Que-treated IHH-exposed
rats compared with IHH-exposed rats (control groups). However, Que administration increased SOD and CAT
activities of the heart tissue in the IHH-exposed rats. Conclusion: HH exposure increases oxidative/nitrosative stress
in heart tissue and Que is an effective cardioprotective agent, which further supports the oxidative cardiac
dysfunction induced by hypoxia.
Keywords: cardioprotection, intermittent hypobaric hypoxia, quercetin, oxidative/nitrosative stress, natural
antioxidants
Introduction
Oxidative/nitrosative stress is involved both in pathological processes and in physiological
processes, such as anaerobic physical exercise, pregnancy, aging, exposure to high altitude
(HA), etc. (13). HA exposure decreases the partial pressure of oxygen and increases
production of reactive oxygen and nitrogen species (RONS) by altering mitochondria
electron transport chains, activating enzymes, such as nicotinamide adenine dinucleotide
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phosphate (NADPH) oxidase, xanthine oxidase/reductase, nitric oxide synthases (NOSs),
etc., as well as by the depletion of cellular enzymatic and non-enzymatic antioxidants (5, 12,
30). In high concentrations, RONS determines the expression of hypoxia-inducible factor-1
alpha (HIF-1α), which then activates over 100 genes involved inclusively in erythropoiesis,
angiogenesis, energy metabolism, proliferation/cell survival, apoptosis, etc., and increases
the expression of inducible NOS (iNOS) (5, 23, 30).
In conditions of hypobaric hypoxia (HH), the nuclear factor kappa B (NF-κB) is
activated, leading to an increase in the expression of HIF-1α, which in turn increases the
synthesis of iNOS and generation of nitric oxide (NO) (30, 41).
The heart is a vital organ for the body that has a strictly aerobic metabolism and is
therefore very vulnerable to low levels of oxygen. Hypoxia induces cardiac apoptosis by the
expression and accumulation of proapoptotic proteins, followed by cardiac remodeling,
biventricular ﬁbrosis, ventricular hypertrophy, left ventricular dysfunction, and heart failure.
Excessive RONS production in the myocardium under the HH exposure conditions induces
cardiomyocytes injury, affecting the structural and functional integrity of the heart (25, 26).
Exposure to long-term or short-term intermittent HH (IHH) has been reported to induce
cardiac damage or cardiac protection in different studies under various conditions (36–40).
Exposure to IHH has the same mechanism of myocardial ischemia/reperfusion injury and is
associated with an increase in RONS production, which is generated during the phase of
reoxygenation of IHH (16). Alteration of NO production plays an important role in heart
injury in conditions of hypoxia/reoxygenation. Excessive NO production by the action of
iNOS in the myocardium rapidly reacts with superoxide anion to form peroxynitrite
(ONOO–), a reactive short-lived peroxide that affects mitochondrial function and triggers
cell death via oxidation and nitration reactions. Peroxynitrite causes myocardial injury and
endothelial dysfunction (1, 22, 31). Controversial effects of IHH on cardiac damage or
cardiac protection are still mysterious.
Flavonoids represent a large group of polyphenolic natural antioxidants present in large
numbers in fruit, vegetables, spices, seeds, red wine, chocolate, etc. (18, 19, 34). Quercetin
(Que) is an essential ﬂavonoid known to be a multifunctional agent due to its antioxidant and
anti-inﬂammatory activity (4, 7).
Recent research has shown in in vitro and in vivo models that Que is an effective
antioxidant by direct scavenge of RONS, including superoxide anion, NO, and peroxynitrite,
and by increasing the endogenous antioxidant activity (4, 19, 21, 27). Several recent researches
have shown that Que has protective effects on different types of cells, including cardiomyo-
cytes, neurons, testis, renal, and liver cells in ischemia/reperfusion injury (2–4, 6, 32).
This study investigates the potential cardioprotective role of Que in HH-induced
cardiomyocyte injury. We have focused on the correlation between Que administration in
cardiomyocytes and the cardioprotective role of Que conducted by decreasing oxidative/
nitrosative stress induced in the heart by HH exposure.
Materials and Methods
Drugs and chemicals
Que was extracted, dosed, and encapsulated at “PROPLANTA”Applied Vegetal Biotechnol-
ogies Center in Cluj-Napoca, Romania. Que was standardized by its chemical composition
using high-performance liquid chromatography method to ensure batch-to-batch consistency.
The Que was suspended in 0.5% carboxymethylcellulose (CMC) solution as a vehicle.
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Animals
Sixty healthy Wistar albino male rats (3-month-old) were used in this study. The rats were
purchased from the Experimental Animal House of the Faculty of Medicine within “Iuliu
Hatieganu” University of Medicine and Pharmacy of Cluj-Napoca, Romania. The rats’
mean weight was 260–325 g at the beginning of the trials. All rats used in the experiment
were kept for 10 days to acclimatize to the conditions of the Animal House Laboratory at
the Physiology Department before being introduced in the study. Throughout the entire
period of the experiment, all rats were maintained in special cages artiﬁcially illuminated
(12-h light–dark cycle), at a temperature of 21–23 °C and at 50%–60% humidity in the
animal room.
The rats were given standard rat pellet diet and water ad libitum. All the experiments
were performed according to the approved animal protocols of the Ethical Committee on
Animal Welfare of “Iuliu Hatieganu” University in accordance with the Romanian Ministry
of Health and complying with Guidelines in the Use of Animals in Toxicology.
IHH-adapted rat model
The IHH treatment consisted of intermittent exposure of Wistar rats to HH (equivalent to an
altitude of 5,500 m, barometric pressure 380 mmHg, 12% O2, and 88% N2) in a hypobaric
chamber (of the Animal House Laboratory at the Physiology Department) for 2 days [short-
term IHH (STIHH) for 8 h/day] and for 4 consecutive weeks [long-term IHH (LTIHH), for
8 h/day, 5 days/week]. The rats were taken out of the hypobaric chamber once after every 8 h
exposure in order to receive water and a standard laboratory diet.
The control rats maintained in normobaric normoxia (Nx) conditions (barometric
pressure 760 mmHg, 21% O2, and 79% N2) for a corresponding period, and were kept
in the same environment as IHH rats with free access to water and food except for hypoxic
exposure.
Experimental design
The rats were randomly divided into following six experimental groups (n= 10). First group
(control group, STNx+CMC) – rats maintained in Nx conditions for short-term and treated
with CMC; second group (control group, STIHH+ CMC) – rats maintained in STIHH
conditions and treated with CMC; third group (STIHH +Que) – rats maintained in STIHH
conditions and treated with Que; fourth group (control group, LTNx +CMC) – rats
maintained in Nx conditions for long-term and treated with CMC; ﬁfth group (LTIHH +
CMC) – rats maintained in (nu e baie calda) LTIHH conditions and treated with CMC; sixth
group (LTIHH +Que) – rats maintained in LTIHH conditions and treated with Que. The Que
was suspended in CMC (0.01 g/ml) and orally administered through an intragastric tube, at a
dose of 20 mg/kg once a day for 2 days and for 4 consecutive weeks, respectively, 30 min
before each IHH exposure. The control groups were treated with vehicle (0.6 ml of CMC)
through an intragastric tube. The body weight (BW) of the rats was measured at the beginning
and at the end of the experiment.
Twenty-four hours after the last exposure to normoxia or hypoxia, all rats were
anesthetized by intraperitoneal administration of sodium pentobarbital (60 mg/rat) and
sacriﬁced by cervical dislocation and the heart of each animal was quickly dissected. Next,
the heart was removed immediately, washed with physiological serum (PS) to remove
residual tissues and blood, weighed, placed into tubes, frozen, and stored at −80 °C.
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Preparation of biological samples
The frozen heart tissue samples were placed into plastic tubes, homogenized at a concentra-
tion of 100 mg tissue per ml of 25 mM buffer (pH 7.4) composed of (in mmol/L): 10 Tris-
HCl, 137 NaCl, 1 Na2EDTA, 0.5 dithiothreitol, and 250 sucrose on ice using a Polytron
homogenizer (Brinkman Kinematica, Switzerland). The homogenate was centrifuged for
10 min at 9,000 × g, and the cellular debris was discarded. The supernatant was allocated into
separate tubes, stored at −80 °C, and used for biochemical assays.
Measurement of biochemical markers of oxidative/nitrosative stress
Because free radicals are highly reactive and have a very short lifetime, we indirectly
measured their levels in the heart tissue homogenates by determining some products of lipid
peroxidation and protein oxidation (protein carbonylation).
Estimation of lipid peroxidation. The lipids are one of the primary targets of reactive oxygen
species (ROS). The peroxidation of lipids produces highly reactive aldehydes, including
malondialdehyde (MDA). The MDA is a primary biomarker of free radical-mediated lipid
damage and oxidative stress. The MDA levels were measured from the heart tissue
homogenate using the ﬂuorimetric method with 2-thiobarbituric acid (TBA) described by
Conti’s method (8). This method was used to obtain a spectroﬂuorimetric measurement of the
color produced during the reaction of TBA with MDA at 535 nm. MDA levels are expressed
as nanomole per milligram protein (nmol MDA/mg protein).
Estimation of protein carbonylation. The protein carbonylation under ROS action was
estimated from the heart tissue homogenate by measuring protein carbonyl (PC) group levels.
The PC derivates that are produced through the protein oxidative damage were determined
using the ﬂuorimetric method with 2,4-dinitrophenyl-hydrazine (29). The readings were
performed using a spectrophotometer at 355–390 nm and to calculate the remaining carbonyl
fragments, the molar extinction coefﬁcient with a value of 22,000/M/cm was used. The levels
of the carbonyl-derivative groups were expressed as nanomole per milligram of protein
(nmol/mg protein).
The activities of some antioxidant enzymes, such as superoxide dismutase (SOD) and
catalase (CAT), in the heart tissue homogenate were also assayed.
Estimation of SOD activity. The SOD activity was assayed using the nitroblue tetrazolium
(NBT) method proposed by Flohe et al. (17). NBT was reduced to blue formazen by
superoxide, which has a strong absorbance at 560 nm. One unit (U) of SOD is deﬁned as the
amount of protein that inhibits the rate of NBT reduction by 50% in 1 min under the assay
conditions. The SOD activity was expressed as units per milligram of protein (U/mg protein).
Estimation of CAT activity. The CAT activity was assayed using the method proposed by
Pippenger et al. (28). The method consists of following the change in absorbance of a solution
of H2O2 (10 mM) in potassium phosphate buffer (0.05 M, pH= 7.4) at 240 nm. One unit of
CAT is deﬁned as the amount of enzyme, which induces 0.43 reduction in absorbance at
25 °C for 3 min. The CAT activity was also expressed as units per milligram of protein
(U/mg protein).
By measuring the free radical production, the levels of nitrosative stress in the heart
tissue homogenate were determined by measuring the NO and iNOS levels.
Estimation of nitrite plus nitrate (NOx) production. The NO production was indirectly
detected by measuring the degradation products of NO, the total nitrite level, after a prior
conversion of nitrates into nitrites under the action of nitrate reductase. The NOx production
was determined by measuring the nitrite, a stable end-product of NO metabolism using the
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Griess reaction (35). The supernatant of heart tissue homogenate was mixed with an equal
volume of Griess reagent followed by spectrophotometric measurement at 543 nm. Nitrite
concentrations in the heart tissue homogenate were determined by comparison to a sodium
nitrite standard curve. The NOx levels are presented as nanomole per milligram of protein
(nmol/mg protein).
Estimation of iNOS. The level of iNOS in the heart tissue homogenate was measured using
the commercially available enzyme-linked immunosorbent assay kits (R&D Systems,
Minneapolis, MN). The iNOS levels are expressed in nanogram per milligram of protein
(ng/mg protein).
Statistical analysis
The statistical analysis was performed using the SPSS software package (version 17.0, SPSS
Inc., Chicago, IL, USA). The data were reported as mean± standard deviation. One-way
analysis of variance (ANOVA) was used to compare differences between groups, and
two-way ANOVA for repeated measurements, followed by Tukey’s multiple post-test
comparisons, to compare the responses of Que and HH. Differences were considered
signiﬁcant, if p< 0.05.
Results
Animal body weights and whole heart weights in the experimental groups after exposure to
STIHH or LTIHH hypobaric hypoxia
The rats exposed to STIHH (STIHH +CMC group) showed insigniﬁcant changes in BW
when compared to the rats maintained in Nx conditions for short-term (STNx+ CMC group)
(Table I). LTIHH exposure signiﬁcantly increased ﬁnal BW (p< 0.05) (LTIHH+ CMC
group). The treatment with Que of the rats exposed to LTIHH (LTIHH+Que) did not
Table I. Effects of short-term (2 days) and long-term (4 weeks) intermittent hypobaric hypoxia and quercetin
administration on body weight (BW) and whole heart weight in control and experimental groups
STNx+
CMC
STIHH+
CMC
STIHH+
Que
LTNx+
CMC
LTIHH+
CMC
LTIHH+
Que
Initial BW (g) 278.8± 11.40 285± 21.41 286.5± 20.24 293± 21.7 275.7± 18.44 293± 28.3
Final BW (g) 278.7± 11.84 287± 21.15 287.6± 21.55 291.7± 22.72 290.3± 19.07 295± 29
Final whole heart
weight (g)
0.79± 0.15 0.84± 0.15 0.86± 0.11 0.99± 0.20 1.16± 0.16a 0.9± 0.09b
Final whole heart
weight/ﬁnal BW
(×103)
2.83± 0.12 2.92± 0.07 2.99± 0.51 3.39± 0.88 3.05± 0.31a 3.05± 0.31a
STNx+CMC: normobaric normoxia conditions for short-term+CMC; STIHH+CMC: short-term intermittent
hypobaric hypoxia+CMC; STIHH+Que: short-term intermittent hypobaric hypoxia+Que; LTNx+CMC:
normobaric normoxia conditions for long-term+CMC; LTIHH+CMC: long-term intermittent hypobaric hypoxia+
CMC; LTIHH+Que: long-term intermittent hypobaric hypoxia+Que. Results are mean± SDof 10 rats per each group.
Statistically signiﬁcant differences are indicated by the symbols: ap< 0.05 vs. LTNx+CMC group; bp< 0.05 vs.
LTIHH+CMC group
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signiﬁcantly increase ﬁnal BW (p> 0.05) as compared to the control rats (LTNx +CMC
group) (Table I).
The ﬁnal whole heart weight did not increase signiﬁcantly following 2 days of exposure
to IHH (STIHH +CMC group; Table I). After 4 weeks of exposure to IHH (LTIHH +CMC
group), signiﬁcant cardiac hypertrophy was observed due to increased ﬁnal whole heart
weight and ﬁnal whole heart weight-to-ﬁnal BW (p< 0.05; Table I). Rats treated with Que
and exposed for 4 weeks to IHH (LTIHH +Que group) showed a signiﬁcant decrease in ﬁnal
whole heart weight and ﬁnal whole heart weight-to-ﬁnal BW (p< 0.05) as compared to the
control rats (LTNx+ CMC and LTIHH+CMC groups) (Table I).
Effects of Que on lipid peroxidation and proteins carbonylation in the heart tissue
homogenate of rats exposed to STIHH or LTIHH
Level of lipid peroxidation. The damage of lipid molecules is indicated by the generation of
MDA. The MDA level in the heart was signiﬁcantly higher (p< 0.0001) after exposure of
animals for either 2 days (STIHH + CMC group) or 4 weeks (LTIHH+ CMC group) to IHH
as compared to the control rats (STNx+ CMC and LTNx+ CMC groups, respectively). After
4 weeks of exposure to IHH (LTIHH +CMC group), the MDA level was higher compared to
the 2 days of exposure to IHH (STIHH+ CMC group), the difference was statistically
signiﬁcant (p< 0.0001) (Fig. 1a). Rats treated with Que and exposed for either
2 days (STIHH +Que group) or 4 weeks (LTIHH +Que group) to IHH showed signiﬁcantly
reduced MDA levels (p< 0.05) in both treated groups as compared to the control rats
(STIHH+ CMC and LTIHH+CMC groups, respectively) (Fig. 1a).
Level of protein oxidation. Reactive PC derivates have been measured as an index of tissue
damage by oxidative stress. The effect of hypoxia on protein oxidation was measured by
determining PC content in heart tissue homogenate. PC-derivative formation (PC groups) in
the heart was also increased (p< 0.0001) in STIHH and LTIHH-exposed animals (STIHH+
CMC and LTIHH+ CMC groups) as compared to the control animals (STNx+ CMC and
LTNx+CMC groups, respectively) (Fig. 1b). The STIHH and LTIHH-exposed rats treated
with Que (STIHH +Que and LTIHH+Que groups) showed signiﬁcantly decreased PC
levels (p< 0.0001) in the heart tissue as compared to the control STIHH and LTIHH-exposed
animals (STIHH+CMC and LTIHH+CMC groups, respectively) (Fig. 1b). Que protected the
heart tissue from protein oxidation induced by IHH exposure (STIHH+Que and LTIHH+
Que groups); protection was statistically the most signiﬁcant (p< 0.0001) in rats exposed to
LTIHH (Fig. 1b).
Effects of Que on the activities of antioxidant enzymes in the heart tissue homogenate of rats
exposed to STIHH or LTIHH
As the biomarkers of the antioxidant defenses, the activities of SOD and CAT in the heart
were measured (Fig. 2).
The SOD activity was very signiﬁcantly decreased (p< 0.0001) in the heart tissue
homogenate after exposure of animals for either 2 days (STIHH +CMC group) or 4 weeks
(LTIHH+CMC group) to IHH as compared to the control animals (STNx+ CMC and
LTNx+CMC groups, respectively), a decrease being statistically signiﬁcant after exposure
to LTIHH (LTIHH +CMC group) (Fig. 2a). Rats treated with Que and exposed to STIHH
(STIHH+Que group) or LITHH (LTIHH +Que group) signiﬁcantly augmented
(p< 0.0001) SOD activity in the heart as compared to the control animals (STIHH +CMC
and LTIHH+ CMC groups, respectively) (Fig. 2a).
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The CAT activity was signiﬁcantly reduced in the heart after exposure of rats for 2 days
(STIHH + CMC group; p< 0.05) or 4 weeks (LTIHH + CMC group; p< 0.0001) to IHH as
compared to the control groups (STNx+ CMC and LTNx+ CMC groups, respectively), a
decrease being statistically signiﬁcant after exposure to LTIHH (LTIHH +CMC group)
(Fig. 2b). Que administration has signiﬁcant effects on the increase of CAT activity in the
Fig. 1. The effects of quercetin on (a) lipid peroxidation (MDA) (nmol/mg protein) and (b) protein oxidation (protein
carbonyl groups) (nmol/mg protein) levels in the heart tissue homogenates of control and experimental rats exposed
to short-term or long-term intermittent hypobaric hypoxia. Results are the mean± SD for 10 animals in each group in
the STNx+CMC, STIHH+CMC, STIHH+Que, LTNx+CMC, LTIHH+CMC, LTIHH+Que groups.
Statistically signiﬁcant differences are indicated by the symbols: ap< 0.0001 vs. STNx+CMC group; bp< 0.05,
bbp< 0.0001 vs. STIHH+CMC group; cp< 0.0001 vs. LTNx+CMC group; dp< 0.0001 vs. LTIHH+CMC group;
ep< 0.0001 LTIHH+CMC group vs. STIHH+CMC group
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heart of rats exposed for 2 days (STIHH+Que group; p< 0.005) or 4 weeks (LTIHH +Que
group; p< 0.0001) as compared to the control animals (STIHH +CMC and LTIHH groups,
respectively) (Fig. 2b).
Fig. 2. The effects of quercetin on the level of (a) superoxide dismutase (SOD) (U/mg protein) and (b) catalase (CAT)
(U/mg protein) activities in the heart tissue homogenates of control and experimental rats exposed to short-term or
long-term intermittent hypobaric hypoxia. Results are the mean± SD for 10 animals in each group in the STNx+
CMC, STIHH+CMC, STIHH+Que, LTNx+CMC, LTIHH+CMC, LTIHH+Que groups. Statistically
signiﬁcant differences are indicated by the symbols: ap< 0.005, aap< 0.0001 vs. STNx+CMC group; bp< 0.005,
bbp< 0.0001 vs. STIHH+CMC group; cp< 0.0001 vs. LTNx+CMC group; dp< 0.0001 vs. LTIHH+ CMC group;
ep< 0.005 LTIHH+CMC group vs. STIHH+CMC group
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Que protected the heart tissue from the oxidative stress induced by IHH (STIHH +Que
and LTIHH+Que groups) exposure, protection evidenced by the increased activities of
antioxidant enzymes (SOD and CAT; Fig. 2).
Fig. 3. The effects of quercetin on the level of (a) nitrite plus nitrate production (NOx) (nmol/mg protein) and
(b) inducible nitric oxide synthase (iNOS) (ng/mg protein) in the heart tissue homogenates of control and
experimental rats exposed to short-term or long-term intermittent hypobaric hypoxia. Results are the mean ± SD
for 10 animals in each group in the STNx + CMC, STIHH + CMC, STIHH +Que, LTNx + CMC,
LTIHH + CMC, LTIHH + Que groups. Statistically signiﬁcant differences are indicated by the symbols:
ap < 0.05 vs. STNx + CMC group; bp < 0.05 vs. STIHH + CMC group; cp < 0.005, ccp < 0.0001 vs.
LTNx + CMC group; dp < 0.005 vs. LTIHH + CMC group; ep < 0.0001 LTIHH + CMC group vs.
STIHH + CMC group
Quercetin protects the heart from hypobaric hypoxia 241
Physiology International (Acta Physiologica Hungarica) 105, 2018
Effects of Que on nitrosative stress in the heart tissue homogenate of rats exposed to STIHH
or LTIHH
Nitrite production. The levels of nitrites (NOx) were measured as indicators of NO
production, which is one of the most important regulatory factors in the cardiovascular
system. After 2 days of exposure to IHH (STIHH + CMC group), the nitrite levels in the heart
were higher (p< 0.05) as compared to the control rats (STNx+CMC group). Nitrites levels
were increased appreciably (p< 0.005) after 4 weeks of exposure to IHH (LTIHH +CMC
group) as compared to the control group (LTNx+ CMC group) (Fig. 3a). Que administration
that is determined signiﬁcantly decreased (p< 0.05) the levels of nitrites in the heart of the
rats exposed for 2 days to IHH (STIHH+Que group) as compared to the control group
(STIHH+ CMC group), the decrease being more signiﬁcant (p< 0.005) in the rats exposed
to LTIHH and treated with Que (LTIHH +Que group) as compared to the control group
(LTIHH+Que group) (Fig. 3a).
iNOS protein expression. The iNOS level in the heart tissue homogenate of the rats exposed
to IHH for 4 weeks (LTIHH + CMC group) was signiﬁcantly higher (p< 0.0001) than that of
the control rats (LTNx+ CMC group). After 2 days of exposure to IHH, the iNOS level in the
heart tissue homogenate was not signiﬁcantly higher (p> 0.05) than that of the control rats
(STNx+CMC group) (Fig. 3b). The rats exposed to IHH for 2 days and treated with Que
(STIHH+Que group) showed non-signiﬁcant decreases in iNOS levels (p> 0.05) in heart
tissue as compared to the control rats (STIHH +CMC group). A signiﬁcant decrease
(p< 0.005) of the iNOS levels was observed in the rats exposed to IHH for 4 weeks and
treated with Que (LTIHH+Que group) as compared to their control rats (LTIHH +CMC
group) (Fig. 3b).
Discussion
This study represents the attempt to observe how the heart reacts to STIHH or LTIHH stress
and the effects of supplementation with natural antioxidants (Que) using an in vivo model.
The ﬁndings of this study were: (1) cardiac hypertrophy was found in rats after 4 weeks of
IHH exposure. However, no signiﬁcant changes of heart weight-to-body weight ratio were
found in the rat’s heart after 2 days of IHH exposure; (2) Que administration signiﬁcantly
decreased the heart weight-to-body weight ratio after a LTIHH exposure; (3) 4 weeks of
exposure to IHH caused a marked increase in ROS generation, lipid peroxidation, and protein
oxidation; (4) the NO production and iNOS level increased signiﬁcantly after 4 weeks of IHH
exposure; (5) enzymatic antioxidant levels decreased in heart tissue after IHH exposure; and
(6) Que supplementation attenuates RONS generation after IHH exposure. Our major
ﬁndings imply that changes of cardiac hypertrophy under IHH exposure are tightly time
course-dependent, and STIHH exposure and Que administration can provide protection from
oxidative/nitrosative stress in hypoxic heart, thus representing a therapeutic strategy in heart
protection in ischemia/reperfusion injuries.
HA is characterized by HH, which is considered a physiological stress characterized by
increasing oxidative/nitrosative stress, consequently causing potential damage to lipids,
proteins, and DNA (33). Oxidative/nitrosative stress increased production of RONS and
decreased intracellular antioxidant defense, thus causing an imbalance in the redox status of
the cell (12, 13). Recent in vitro and animal research have demonstrated the involvement of
RONS in impairment of the cardiovascular system in response to various heart stressors
(2, 6). Exposure to IHH increases RONS generation in the myocardium, which appears to be
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the main cause of myocardial damage. RONS produced in excess in the myocardium cause
cardiomyocyte injury, apoptosis, and cell necrosis (42). In this study, cardiac hypertrophy
was observed after long-term exposure to IHH, as evidenced by the signiﬁcant increase in the
heart weight-to-body weight ratio. After 2 days of IHH exposure, the rats showed a less
signiﬁcant cardiac hypertrophy. Our results are in accordance with recent data; the main
consequences of adaptation to HH are an increased cardiac resistance to acute ischemic injury
and myocardial hypertrophy (33). In the hypoxic heart, cardiomyocyte apoptosis occurs with
the distortion of cardiac architecture. Therefore, after long-term exposure to IHH, myocardial
ﬁbrosis and ventricular hypertrophy with myocardial dysfunction and heart failure occur. On
the contrary, short-term exposure to IHH provides myocardial protection against myocardial
injury. The protective effects would promote myocardial contractile recovery of cardiac
function in ischemia/reperfusion injury, limiting myocardial infarction, and cardiac arrhyth-
mias (36–39). The rats treated with Que and exposed to LTIHH showed a signiﬁcant decrease
in the heart weight-to-body weight ratio, demonstrating cardioprotective effects. These data
complete our previous studies and results of other researchers that showed the cardiopro-
tective effects of Que in ischemia/reperfusion injury (6, 14, 15).
In this study, we investigated the oxidative/nitrosative stress induced in the rat’s heart by
IHH exposure and the possible cardioprotective effects of Que supplementation. Our data
clearly suggest that IHH exposure determines a signiﬁcant RONS generation in heart tissue.
RONS generation after IHH exposure caused further damage to cardiomyocyte membrane
composition.
This study demonstrates that STIHH or LTIHH exposure induces increase in oxidative
stress in the heart, which is proven by the growth of lipid peroxidation and protein oxidation
in the heart tissue homogenate, as previously reported (16).
Lipids undergo peroxidation in the presence of RONS and oxygen. MDA, a major
oxidant product of membrane-peroxidized polyunsaturated fatty acids, is an indicator for
oxidative stress. MDA level indirectly reﬂects the severity of peroxidation damage in body
cells attacked by free radicals. It is one of the indicators to evaluate organism ischemic injury.
MDA level in STIHH group had changed signiﬁcantly, which indicated that lipid peroxida-
tion occurred in early HH stage. Protein modiﬁcations caused by RONS include formation of
carbonyls, dityrosine, and nitrated and chlorinated tyrosines (13). Our results are in
accordance with the results obtained by other researchers (16, 42). After exposure to LTIHH,
the products of the lipid and protein oxidative damage in the heart tissue homogenate
increased more signiﬁcantly (p< 0.0001), as opposed to exposure to STIHH. These studies
demonstrated that Que plays a protective role in the heart of rats exposed to IHH as a result of
products of lipid peroxidation, demonstrated by lower MDA content, and protein oxidation,
demonstrated by decreasing PC content in the heart tissue homogenate. The effect of Que was
corroborated by changes in heart weight. This view of protective role of Que in heart tissue is
supported by our previous studies in which we observed the restoration of cardiac architec-
ture in rats exposed to LTIHH after treatment with Que (15).
To correlate the results obtained from the investigation of oxidative stress after STIHH
and LTIHH exposure, we monitored some antioxidant enzymes’ activities such as SOD and
CAT in the heart tissue, enzymes responsible for scavenging RONS. SOD is one very
important enzymatic scavenger as it plays a critical role in protecting mitochondria from
superoxide anions generated during respiration. It accelerates the dismutation of superoxide
anions into hydrogen peroxide, which can be regarded as a primary defense in preventing the
generation of free radicals (10). CAT is localized intracellularly in the mitochondria and
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peroxisomes and is responsible for scavenging the hydrogen peroxide resulting from
superoxide anions after SOD action (13, 19). In this study, we have shown that hypoxia
is associated with decreased SOD and CAT concentrations in the heart of rats exposed to IHH
for either 2 days or 4 weeks. Que supplementation in rats exposed to IHH signiﬁcantly
increased the activity of antioxidant enzymes (SOD and CAT) in the heart tissue, which then
may help to protect the heart from oxidative damage. The accumulation of damaged products
is probably partially prevented by the elevated activities of antioxidant enzymes (SOD and
CAT) in the heart. These results are in concordance with other reports that demonstrated
antioxidative actions of Que in different tissues (2–4, 6, 14, 15, 24, 32).
To fully elucidate the effects of IHH exposure in the animal, we studied NO, one of the
main candidates to accord the cardioprotection effect at HA (33, 39, 42). This study
demonstrated that 2 days of IHH exposure increased NO production. Excessive NO production
after STIHH exposure had the role of protecting the hypoxic heart. In the heart, after exposure to
HH, NF-κB is activated, increasing the expression of HIF-1α, which in turn expands the
generation of NO (30, 41). Excessive NO production in the hypoxic heart is responsible for
increasing erythropoiesis, vascularization, and vasodilatation in the heart and therefore cardi-
oprotection. After exposure to LTIHH, the NO production and iNOS level in the heart tissue
homogenate increased more signiﬁcantly. NO in high concentration exerts pathological effects
by rapidly interacting with superoxide anion; even low concentrations can form peroxynitrite
(9). The peroxynitrite radical causes lipid peroxidation, apoptosis, DNA alterations, nitration,
and oxidation of proteins, causing destruction determined in the cardiomyocytes (31).
This study also reports that the source of increased NO production after exposure to
LTIHH may be iNOS, showing an increase in nitrosative stress in the heart responsible for
cardiac damage. In our research, after 2 days of IHH exposure, there was a non-signiﬁcant
increase in the iNOS production in the heart, but after 4 weeks of IHH exposure, the
concentrations of iNOS increased very signiﬁcantly in the heart tissue. These results conﬁrm
that exposure of the heart to STIHH has cardioprotective effects, whereas long exposure to
IHH causes cardiac damage.
In this study, the rats treated with Que and exposed to LTIHH showed a signiﬁcant
decrease in the NO produced and in the iNOS level of the heart. The results from this study
also suggest that Que modulates its cardioprotective effects by the enhancement of NO
bioavailability through the metabolism of superoxide anions and/or its reactive metabolites
and by directly scavenging ROS and free radicals and activating antioxidant enzymes (4, 15),
data which were in agreement with other ﬁndings recently reported by other authors (4, 11,
20, 21). Recent research shows that Que inhibits the NADPH oxidase complex that mediates
the synthesis of superoxide anion and inhibits iNOS expression and thus decreases the
concentration of NO, an effect mediated by inhibition of nuclear translocation of NF-κB (21).
The present results showed that STIHH exposure induces cardioprotection in hypoxic
heart, and LTIHH exposure induces the growth of oxidative/nitrosative stress in the heart,
which is ultimately responsible for cardiac damage. Que supplementation exerted a protective
effect against the markers of cardiac cell stress.
Conclusions
In conclusion, our data demonstrate that Que exerts cardioprotective effects in the heart of
rats exposed to IHH. These beneﬁcial actions of Que were mediated by antioxidant protection
of oxidative stress coupled with neutralizing reactive metabolites of NO. Furthermore, these
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results suggest that Que administration before exposure to hypoxia may have beneﬁcial
effects against cardiac damage circumscribed by oxidative/nitrosative stress.
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